Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer
- 1 October 2006
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 7 (10), 859-868
- https://doi.org/10.1016/s1470-2045(06)70905-6
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Expanding the Use of Magnetic Resonance in the Assessment of Tumor Response to Therapy: Workshop ReportCancer Research, 2005
- MRI in treatment of adult gliomasThe Lancet Oncology, 2005
- Proton magnetic resonance spectroscopy of brain tumors correlated with pathology1Academic Radiology, 2005
- MR spectroscopy of brain tumorsMagnetic Resonance Imaging Clinics of North America, 2003
- Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesionsNeuroradiology, 2002
- Brain Biopsy Using High-Field Strength Interventional Magnetic Resonance ImagingNeurosurgery, 1999
- Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumorsCancer, 1997
- Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopyNature Medicine, 1996
- Accuracy of Digital Rectal Examination and Transrectal Ultrasonography in Localizing Prostate CancerJournal of Urology, 1994
- Application ofin vivo NMR spectroscopy to cancerMagnetic Resonance in Medicine, 1984